- active not recruitingEARLY_PHASE1
Vaccine Pandemic Preparedness Through Airway Immunology Characterization
This study compares different flu vaccines (nasal spray vs. jab) in healthy adults aged 18-49. It aims to find better ways to protect against flu by understanding how our bodies react to vaccines and improving future vaccine development.
Denmark · United Kingdom - recruitingPHASE2
An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection
This study is looking at a medicine called zanamivir given through a drip to treat babies under 6 months who are in hospital with flu. We want to understand how their bodies handle the medicine and if it's safe for them.
Italy · Poland · Spain - ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2a randomized, observer-blind, study to evaluate the immunogenicity and safety of mRNA-based multivalent seasonal influenza vaccine candidates in adults 18 years of age and older.
This study is testing new flu vaccines for adults aged 18 and over. It aims to see how well these new vaccines help your body fight the flu and if they are safe to use. We want to find out if they cause any side effects.
Belgium - ongoing, recruitingTherapeutic exploratory (Phase II)
An open label, single arm study to evaluate single and multiple dose pharmacokinetics, safety and tolerability, and to explore clinical outcomes of treatment with intravenous (IV) zanamivir in neonates and infants under 6 months of age with confirmed complicated influenza infection.
This study is looking at a medicine called zanamivir, given through a drip, for babies under 6 months old who have severe flu. We want to understand how the medicine works in their bodies and if it helps them get better. It's an early-stage study to see if it's safe and effective for these very young children.
Spain · Italy